SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-2057PMID 16489032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/+ (Min/+) mouse.

  2005cited by this paper
• Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells.

  2005cited by this paper
• beta-catenin and its regulatory network.

  2005cited by this paper
• Wnt, stem cells and cancer in the intestine

  2005cited by this paper
• Inhibition of beta-catenin-mediated transactivation by flavanone in AGS gastric cancer cells.

  2005cited by this paper
• β-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation

  2005cited by this paper
• β-catenin and its regulatory network

  2005cited by this paper
• Inhibition of β-catenin-mediated transactivation by flavanone in AGS gastric cancer cells

  2005cited by this paper
• SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models.

  2005cited by this paper
• Decisions, decisions: beta-catenin chooses between adhesion and transcription.

  2005cited by this paper
• Acetylation of β-Catenin by p300 Regulates β-Catenin-Tcf4 Interaction

  2004cited by this paper
• Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex.

  2004cited by this paper
• Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex

  2004cited by this paper
• beta-catenin-mediated signaling: a molecular target for early chemopreventive intervention.

  2004cited by this paper
• Convergence of Wnt, ß-Catenin, and Cadherin Pathways

  2004cited by this paper
• Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.

  2004cited by this paper
• Convergence of Wnt, beta-catenin, and cadherin pathways.

  2004cited by this paper
• Activation of beta-catenin-TCF-mediated transcription by non-receptor tyrosine kinase v-Src.

  2004cited by this paper
• Nitric oxide-donating aspirin inhibits β-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β-catenin–TCF association

  2003cited by this paper
• SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.

  2003cited by this paper
• Tumor formation by genetic mutations in the components of the Wnt signaling pathway

  2003cited by this paper
• Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association.

  2003cited by this paper
• Specific inhibition of gene expression using a stably integrated, inducible small‐interfering‐RNA vector

  2003cited by this paper
• Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells.

  2002cited by this paper
• β-catenin - A linchpin in colorectal carcinogenesis?

  2002cited by this paper
• β-Catenin-mediated transactivation and cell–cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells

  2002cited by this paper
• The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.

  2002cited by this paper
• Molecular causes of colon cancer

  2002cited by this paper
• A transcriptional response to Wnt protein in human embryonic carcinoma cells

  2002cited by this paper
• Inhibition of beta-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations.

  2002cited by this paper
• The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.

  2002cited by this paper
• The -Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells

  2002influential reference
• Beta-catenin--a linchpin in colorectal carcinogenesis?

  2002cited by this paper
• The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.

  2001cited by this paper
• Regulation of beta-catenin structure and activity by tyrosine phosphorylation.

  2001cited by this paper
• Structure of a human Tcf4-beta-catenin complex.

  2001cited by this paper
• The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signaling

  2001cited by this paper
• Structure of a human Tcf4–β-catenin complex

  2001cited by this paper
• All Tcf HMG box transcription factors interact with Groucho-related co-repressors.

  2001cited by this paper
• Regulation of β-Catenin Structure and Activity by Tyrosine Phosphorylation*

  2001influential reference
• Lack of mutation at codon 531 of SRC in advanced colorectal cancers from Italian patients

  2001cited by this paper
• β-Catenin–Histone Deacetylase Interactions Regulate the Transition of LEF1 from a Transcriptional Repressor to an Activator

  2000cited by this paper
• Activating SRC mutation in a subset of advanced human colon cancers

  1999cited by this paper
• Regulation of E-cadherin/Catenin Association by Tyrosine Phosphorylation*

  1999cited by this paper
• Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

  1999cited by this paper
• Absence of genetic alteration at codon 531 of the human c-src gene in 479 advanced colorectal cancers from Japanese and Caucasian patients.

  1999cited by this paper
• β-Catenin regulates expression of cyclin D1 in colon carcinoma cells

  1999cited by this paper
• Phosphorylation and Free Pool of β-Catenin Are Regulated by Tyrosine Kinases and Tyrosine Phosphatases during Epithelial Cell Migration*

  1999cited by this paper
• Functional Characterization of Multiple Transactivating Elements in β-Catenin, Some of Which Interact with the TATA-binding Proteinin Vitro *

  1999cited by this paper
• Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling

  1998cited by this paper
• Identification of c-MYC as a target of the APC pathway.

  1998cited by this paper
• Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potential.

  1997cited by this paper
• Expression of the HGF/SF receptor, c-met, and its ligand in human colorectal cancers.

  1997cited by this paper
• Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.

  1997cited by this paper
• Tyrosine phosphorylation and cadherin/catenin function

  1997cited by this paper
• Functional interaction of β-catenin with the transcription factor LEF-1

  1996cited by this paper
• Functional interaction of beta-catenin with the transcription factor LEF-1.

  1996cited by this paper
• Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis.

  1994cited by this paper
• Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.

  1993cited by this paper
• Study of c‐erbB‐2 protein and epidermal growth factor receptor expression and DNA ploidy pattern in colorectal carcinoma

  1993cited by this paper
• Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis.

  1990cited by this paper
• Analysis of pp60c-src in human colon carcinoma and normal human colon mucosal cells.

  1987cited by this paper
• human colorectal cancer

  year unknowncited by this paper

• A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumors

  2023cites this paper
• Coinfection of HPVs Is Associated with Advanced Stage in Colorectal Cancer Patients from Qatar

  2023cites this paper
• Human Papillomaviruses-Related Cancers: An Update on the Presence and Prevention Strategies in the Middle East and North African Regions

  2022cites this paper
• A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer

  2022cites this paper
• A reversible SRC-relayed COX2-inflammatory program drives therapeutic resistance in BRAFV600E colorectal tumors

  2022cites this paper
• Anti-Metastatic Effect of Pyruvate Dehydrogenase Kinase 4 Inhibition in Bladder Cancer via the ERK, SRC, and JNK Pathways

  2022cites this paper
• Taking the road less traveled – the therapeutic potential of CBP/β-catenin antagonists

  2021cites this paper
• Estrogen Receptor Signaling Pathways Involved in Invasion and Colony Formation of Androgen-Independent Prostate Cancer Cells PC-3

  2021cites this paper
• Integrins as attractive targets for cancer therapeutics

  2021cites this paper
• Human Papillomaviruses and Epstein–Barr Virus Interactions in Colorectal Cancer: A Brief Review

  2020cites this paper
• Enhanced Kat3A/Catenin transcription: a common mechanism of therapeutic resistance

  2019cites this paper
• Drug Design and Synthesis of First in Class PDZ1 Targeting NHERF1 Inhibitors as Anticancer Agents

  2019cites this paper
• BCR-ABL Inhibitors as Sensitizing Agents for Cancer Chemotherapy

  2019cites this paper
• β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy

  2018influential citation
• Morphomechanical Alterations Induced by Transforming Growth Factor-β1 in Epithelial Breast Cancer Cells

  2018cites this paper
• Tunable mechanical properties of stent-like microscaffolds for studying cancer cell recognition of stiffness gradients

  2018cites this paper
• Wnt Signaling in Stem Cells and Cancer Stem Cells: A Tale of Two Coactivators.

  2018cites this paper
• Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone

  2018cites this paper
• Xom induces proteolysis of β‐catenin through GSK3β‐mediated pathway

  2018cites this paper
• Bosutinib: A Potent Second-Generation Tyrosine Kinase Inhibitor.

  2018cites this paper
• CBP/Catenin antagonists: Targeting LSCs' Achilles heel.

  2017cites this paper
• Actin-Based Adhesion Modules Mediate Cell Interactions with the Extracellular Matrix and Neighboring Cells.

  2017cites this paper
• Paving the Rho in cancer metastasis: Rho GTPases and beyond.

  2017cites this paper
• A Src/Abl kinase inhibitor, bosutinib, downregulates and inhibits PARP enzyme and sensitizes cells to the DNA damaging agents

  2017cites this paper
• EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling

  2016cites this paper
• Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells

  2016cites this paper
• The role of cancer related inflammation, Src family kinases and matrix metalloproteinase 9 in colorectal cancer

  2016cites this paper
• Histamine prevents radiation-induced mesenchymal changes in breast cancer cells.

  2016cites this paper
• Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulation

  2016cites this paper
• Use of genetically engineered mouse models in preclinical drug development

  2015cites this paper
• Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion

  2015cites this paper
• Transglutaminase 2-Mediated Gene Regulation

  2015cites this paper
• Tubedown regulation of retinal endothelial permeability signaling pathways

  2015influential citation
• An aberrant nuclear localization of E-cadherin is a potent inhibitor of Wnt/β-catenin-elicited promotion of the cancer stem cell phenotype

  2015cites this paper
• The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targets

  2015cites this paper
• Impact of P-cadherin expression in the modulation of E-cadherin adhesive function in cancer cells

  2014cites this paper
• Tyrosine Phosphorylation Events in Mouse Sperm

  2014cites this paper
• Bosutinib: a novel second-generation tyrosine kinase inhibitor.

  2014cites this paper
• An immunofluorescent method for characterization of Barrett's esophagus cells.

  2014cites this paper
• Can we safely target the WNT pathway?

  2014cites this paper
• Targeting the β-catenin nuclear transport pathway in cancer.

  2014cites this paper
• Tyrosine phosphorylation of LRP6 by Src and Fer inhibits Wnt/β‐catenin signalling

  2014cites this paper
• The role of Src kinase in renal cell carcinoma

  2014cites this paper
• The role of N-Src kinases in neuronal differentiation

  2014cites this paper
• Regulation of Amyloid Precursor Protein Processing by Serotonin Signaling

  2014cites this paper
• The Role of Calcium Transients in the Collective Migration of Goldfish Epithelial Keratocytes

  2014cites this paper
• Safely targeting cancer stem cells via selective catenin coactivator antagonism

  2014cites this paper
• Silencing of pancreatic adenocarcinoma upregulated factor by RNA interference inhibits the malignant phenotypes of human colorectal cancer cells.

  2013cites this paper
• Prerequisite Genetic Traits for Metastasis

  2013cites this paper
• Tissue transglutaminase regulates β‐catenin signaling through a c‐Src‐dependent mechanism

  2013cites this paper
• Dasatinib inhibits mammary tumour development in a genetically engineered mouse model

  2013cites this paper
• Characterization of Jak, STAT, and Src interactions in Head and Neck Squamous Cell Carcinoma

  2013cites this paper
• Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion

  2013cites this paper
• In Vitro Drug Response and Efflux Transporters Associated with Drug Resistance in Pediatric High Grade Glioma and Diffuse Intrinsic Pontine Glioma

  2013cites this paper
• E-cadherin–integrin crosstalk in cancer invasion and metastasis

  2013influential citation
• ANNA BALIKOVA Studies on the functions of tumor-associated mucin-like leukosialin (CD43) in human cancer cells

  2012cites this paper
• SKI-606, an Src Inhibitor, Reduces Tumor Growth, Invasion, and Distant Metastasis in a Mouse Model of Thyroid Cancer

  2012cites this paper
• Src-mediated regulation of E-cadherin and EMT in pancreatic cancer.

  2012cites this paper
• Adherens junctions and cancer.

  2012cites this paper
• Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells.

  2012cites this paper
• 4-Aryl-4H-naphthopyrans derivatives: one-pot synthesis, evaluation of Src kinase inhibitory and anti-proliferative activities

  2012cites this paper
• Wnt/beta-Catenin Signaling and Small Molecule Inhibitors

  2012cites this paper
• STIM1 tyrosine-phosphorylation is required for STIM1-Orai1 association in human platelets.

  2012cites this paper
• The Wnt signaling pathways and cell adhesion.

  2012cites this paper
• Adherens junctions during cell migration.

  2012cites this paper
• Molecular Analysis And Detection Of Specific Mutations In K-ras (kirstein Ras Viral Oncogene Homologue) In Pakistani Colorectal Cancer Patients

  2012cites this paper
• Nonreceptor Tyrosine Kinases and Their Roles in Cancer

  2012cites this paper
• Current status of SRC inhibitors in solid tumor malignancies.

  2011cites this paper
• that Regulates C/EBPδ Expression and Contributes to Transformation of

  2011cites this paper
• Specific Oncogenic Activity of the Src-Family Tyrosine Kinase c-Yes in Colon Carcinoma Cells

  2011cites this paper
• Acquired endocrine resistance in breast cancer: implications for tumour metastasis.

  2011cites this paper
• Identification of a Src Tyrosine Kinase/SIAH2 E3 Ubiquitin Ligase Pathway That Regulates C/EBPδ Expression and Contributes to Transformation of Breast Tumor Cells

  2011cites this paper
• Src-mediated regulation of homotypic cell adhesion: implications for cancer progression and opportunities for therapeutic intervention.

  2011cites this paper
• The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.

  2011cites this paper
• SHP-1 inhibits β-catenin function by inducing its degradation and interfering with its association with TATA-binding protein.

  2011cites this paper
• Src kinase: a therapeutic opportunity in endocrine-responsive and resistant breast cancer

  2011cites this paper
• Regulation of Src Family Kinases in Human Cancers

  2011cites this paper
• Chronic myelogenous leukemia (CML)

  2010cites this paper
• Activation of Wnt Signaling Pathway by Human Papillomavirus E6 and E7 Oncogenes in HPV16-Positive Oropharyngeal Squamous Carcinoma Cells

  2010cites this paper
• Optimizing therapy for patients with chronic myelogenous leukemia in chronic phase

  2010cites this paper
• The role of Src kinase and Src kinase family members in breast cancer

  2010cites this paper
• Loss of Cadherin-Catenin Adhesion System in Invasive Cancer Cells

  2010cites this paper
• Control of mammary tumor differentiation by SKI-606 (bosutinib)

  2010cites this paper
• PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo

  2010cites this paper
• Bosutinib.

  2010cites this paper
• Modulation of Philadelphia Chromosome-Positive Hematological Malignancies by the Bone Marrow Microenvironment

  2010cites this paper
• SRC: a century of science brought to the clinic.

  2010cites this paper
• Is Src a viable target for treating solid tumours?

  2010cites this paper
• Locking Src/Abl Tyrosine Kinase Activities Regulate Cell Differentiation and Invasion of Human Cervical Cancer Cells Expressing E6/E7 Oncoproteins of High-Risk HPV

  2010cites this paper
• Bosutinib: a review of preclinical studies in chronic myelogenous leukaemia.

  2010cites this paper
• The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy.

  2010cites this paper
• Src signaling in cancer invasion

  2010cites this paper
• Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma

  2009cites this paper
• Targeting Src signaling in metastatic bone disease

  2009cites this paper
• Mislocalization of cell-cell adhesion complexes in tamoxifen-resistant breast cancer cells with elevated c-Src tyrosine kinase activity.

  2009cites this paper
• Adhesive and signaling functions of cadherins and catenins in vertebrate development.

  2009cites this paper
• Tyrosine phosphorylation events in mouse sperm capacitation

  2009cites this paper
• Autocrine loop for IGF-I receptor signaling in SLUG-mediated epithelial-mesenchymal transition.

  2009cites this paper
• Epidermal growth factor receptor/beta-catenin/T-cell factor 4/matrix metalloproteinase 1: a new pathway for regulating keratinocyte invasiveness after UVA irradiation.

  2009cites this paper
• Src kinases as therapeutic targets for cancer

  2009cites this paper